Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cortexyme Inc
(NQ:
CRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 29, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cortexyme Inc
< Previous
1
2
Next >
Cortexyme Expands Proprietary Development Pipeline with Initiation of Phase 1 Clinical Trial of COR588
September 08, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th
September 07, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme Presents New Data Demonstrating Evidence of P. Gingivalis Infection of the Central Nervous System in Alzheimer’s Disease at Annual Biomarkers for Alzheimer’s Disease Summit
August 25, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at Annual Biomarkers for Alzheimer’s Disease Summit
August 18, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme Provides Business Update and Reports Second Quarter 2021 Results
August 09, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at Canaccord Genuity' s 41st Annual Growth Conference on August 11th
August 04, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme Presents Data Linking P. Gingivalis to Elevated Levels of Phospho-tau217 Reinforcing Evidence of Pathogen as Causative Agent of Alzheimer’s Disease at AAIC 2021
July 26, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme Announces Lead 3CLpro Inhibitor for the Treatment of Coronavirus Infection
July 23, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present New Data at AAIC 2021
July 22, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme Presents New Data Demonstrating Atuzaginstat Disrupts Biofilms and is Efficacious in Preclinical Models of Periodontal Disease at IADR 2021
July 21, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Host Symposium at AAIC 2021
July 19, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Host Two-Part Key Opinion Leader Webinar Series on Atuzaginstat
July 08, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme Presents Updated Baseline Data from Complete Set of Participants Enrolled in Pivotal GAIN Trial at ASCP 2021 Annual Meeting
June 01, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at Investor Conferences in June 2021
May 26, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme Provides Business Update and Reports First Quarter 2021 Results
May 10, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021
May 04, 2021
From
Cortexyme, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.